Filter
252
Featured
Recommendations
22
New Publications
27
Language
Document type
No document type
140
Studies & Reports
30
Manuals
28
Guidelines
22
Fact sheets
13
Strategic & Response Plan
10
Training Material
3
Situation Updates
2
Resource Platforms
2
Brochures
1
Videos
1
Countries / Regions
Global
7
Latin America and the Carribbean
6
Western and Central Europe
6
Eastern Europe
5
South–East Asia Region
4
Germany
3
Kenya
3
Colombia
3
Nigeria
2
India
2
Indonesia
2
Bangladesh
2
Malawi
2
Mozambique
2
Argentina
2
Brazil
2
Ecuador
2
El Salvador
2
Myanmar / Burma
2
Chile
2
Timor Leste/ East Timor
2
Russia
2
Congo, Democratic Republic of
1
Guinea-Bissau
1
Uganda
1
Nepal
1
Pakistan
1
Tanzania
1
South Africa
1
Peru
1
Ukraine
1
Angola
1
Sri Lanka
1
Eastern Europe and Central Asia
1
Paraguay
1
Asia
1
Bhutan
1
North Korea
1
Tajikistan
1
Authors & Publishers
Publication Years
Category
Countries
34
Clinical Guidelines
24
Public Health
9
Key Resources
5
Pharmacy & Technologies
4
Women & Child Health
2
Capacity Building
1
The roadmap describes the actions needed to
achieve the three development goals for TB
vaccines set by the WHO:
1. A safe, effective and affordable TB vaccine
for adolescents and adults.
2. An affordable TB vaccine for neonates and
infants with improved safety and efficacy.
3. A therapeutic v
...
5 May 2021
This Information Note is intended to assist national TB programmes and health personnel worldwide to maintain essential tuberculosis (TB) services during the COVID-19 pandemic and in the recovery phase. It is important that recent progress made in TB prevention and care is not reversed b
...
This regional report on the situation of tuberculosis (TB) in the Americas contains information from 2019, provided by the countries of the Region through the World Health Organization TB data collection system. These data have been consolidated and analyzed at the regional level. In addition to pre
...
Tuberculosis (TB) is, and should be, a curable disease; however, each year significant numbers of patients acquire or develop drug-resistant TB, which has a much lower cure rate. Patients with drug-resistant TB have a high prevalence of symptoms; hence, staff caring for these patients should h
...
Tuberculosis (TB) is the leading cause of death from a single infectious agent even if is largely curable and
preventable. In 2019 an estimated 2.9 million of the 10 million people who fell ill with TB were not
diagnosed or reported to the World Health Organization1. The Politi
...
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’s Digital Health for the End TB Strategy – an Agenda for Action o
...
La nueva hoja de ruta para poner fin a la TB en la población infantil y adolescente tiene un amplio público destinatario y alentamos a los países a que la adapten en función de su contexto nacional. Se prevé que utilicen la hoja de ruta los encargados de formular políticas a nivel nacional, re
...
Este documento presente es para brindar lineamientos al personal del Sistema Nacional Integrado de Salud que atiende casos o personas con sospecha de TB durante el período de emergencia por el COVID-19. Incluye directrices de la distribución del medicamento antifimico a los establecimientos de sa
...
Este documento brinda orientaciones y directrices técnicas para mantener las acciones para la prevención y control de la tuberculosis (TB), ante la coyuntura que representa la pandemia del COVID-19 en Colombia, de conformidad con las directrices y recomendaciones emitidas por la Organización Mund
...
Quick guide to video-supported treatment of tuberculosis (2020).
Despite being a curable and preventable disease, tuberculosis (TB) remains as one of the major challenges for health systems, globally. Every year, TB affects more than 10 million people and kills more than 1.4 million people. WHO’
...
The Global Strategy for Tuberculosis Research and Innovation will support the efforts of governments and other stakeholders to accelerate TB research and innovation, and improve equitable access to the benefits of research.
Availabl in Arabic, Chinese, English, French, Spanish and Russian
